APUS
ApimedsยทAMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
APUS Profile
Apimeds Pharmaceuticals Us, Inc.
A clinical stage biopharmaceutical company
Pharmaceutical
05/11/2020
05/09/2025
American Stock Exchange
2
12-31
Common stock
2 East Broad Street 2nd Floor, Hopewell, NJ 08425
--
Apimeds Pharmaceuticals US, Inc., was incorporated in Delaware on May 11, 2020. They are a clinical-stage biopharmaceutical company developing Apitox, an intradermal injection of bee venom toxin. Their focus is primarily on developing innovative therapies to address inflammation and pain management symptoms associated with knee OA.
